Diabetes

Predictors of poor medication adherence include increased regimen complexity, multiple comorbidities, and high medication cost.

Supplementing insulin therapy combined with other glucose lowering agents may improve outcomes for T1DM patient.

Supplementing insulin therapy combined with other glucose lowering agents may improve outcomes for T1DM patient.

More than 20,000 articles have been written on how poor medication adherence, which costs the United States between $68 to $146 billion annually, increases adverse clinical outcomes and mortality.

Once-daily, long-acting basal insulin was approved in September 2015 for improving glycemic control in adults with diabetes.

Once-daily, long-acting basal insulin was approved in September 2015 for improving glycemic control in adults with diabetes.

Novo Nordisk's insulin degludec injection is now available in pharmacies nationwide.

Some studies have reported an association between marijuana use and individual metabolic syndrome factors, while others have found no relationship.

Prescription-only technology with insurance reimbursement helps patients and prescribers better manage diabetes.

The FDA today approved Eli Lilly's Humulin R U-500 insulin human injection (KwikPen) for patients with type 1 and type 2 diabetes who need more than 200 units of insulin per day.

Metformin decreased inflammation and scarring observed in more common pancreatic cancers.

Diabetes associated with a 60% increased risk of dementia for both men and women.

Diabetes associated with a 60% increased risk of dementia for both men and women.

Because diabetes is among the most common conditions for which pharmacies will dispense medications, a number of pharmacy technicians seek to better understand the disease.

Patients with type 2 diabetes have about a 60% greater risk for developing dementia than their non-diabetic counterparts.

Many patients with diabetes have high levels of mental illness, multiple comorbidities, and unmet needs.

There are some specific questions that pharmacist should ask when counseling type 2 diabetics.

Caregivers will be able to monitor glucose data and administer insulin right from the pump.

Caregivers will be able to monitor glucose data and administer insulin right from the pump.

Children ages 2 to 17 years will now be allowed to use the Animas Vibe insulin pump and continuous glucose monitoring system for diabetes management.

Device should be used in conjunction with standard diabetic ulcer care.

Disappointing sales were blamed on prior authorization, the FDA label restrictions, and the need for spirometry before doctors could write prescriptions.

Patients with certain diabetic foot ulcers now have a new treatment option.

Pharmacists are powerful advocates for insulin adherence in patients with diabetes.

A middle-aged man experienced complete remission of type 2 diabetes after cure of chronic hepatitis C virus.